Clinical research in cardiology : official journal of the German Cardiac Society · 2026
Reduced right/left ventricular blood pool T2-ratio predicts congestive heart failure after STEMI.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Troger Felix, Pamminger Mathias, Tiller Christina, Holzknecht Magdalena, Lechner Ivan, Kaser Alex, Lungenschmid Philip, Popa Ramona, Oberhollenzer Fritz, Reindl Martin, Metzler Bernhard, Reinstadler Sebastian J, Mayr Agnes
Аннотация
BACKGROUND: T2-mapping of the blood-pool in cardiac magnetic resonance imaging (CMR) provides important information on blood-oxygenation, and differences between right and left ventricular (RV/LV) T2-relaxation times are linked to exercise capacity in heart failure. However, there are no data available on RV/LV T2-ratio after ST-segment elevation myocardial infarction (STEMI). Our aim was to investigate the prognostic value of RV/LV T2-ratio for the development of newly diagnosed congestive heart failure (CHF) post-STEMI.
METHODS: Six hundred four patients were enrolled after revascularized first-time STEMI; all patients underwent CMR within four days afterwards (interquartile range (IQR) 2-5). T2 relaxation times were measured in the RV and LV blood pool on short-axis T2-maps; T2-ratio was calculated as T2RV/T2LV. Telephonic follow-ups were performed at a median observation interval of 3.0 years. CHF was defined as cardiac decompensation symptoms requiring i.v. diuretics.
RESULTS: Median T2-ratio was 73% (IQR 65-80) and significantly lower in patients with newly diagnosed CHF (69% vs. 73%, p = 0.019). Dichotomized at 60% (10th percentile), patients with a reduced T2-ratio experienced CHF significantly more often (19% vs. 6%, p < 0.001) and sooner (55 vs. 485 days, p < 0.001) and were significantly older, had larger infarcts, higher peak troponin T, N-terminal pro-brain natriuretic peptide (NT-proBNP), lower LV-/RV-ejection fraction, and more commonly microvascular injuries (all p < 0.05). In logistic regression, T2-ratio < 60% emerged as an independent prognostic marker in multiparametric models including classic CHF risk factors. Addition of RV/LV T2-ratio to NT-proBNP resulted in a net reclassification improvement of 0.32 (95% CI 0.06-0.57, p = 0.016).
CONCLUSION: CMR-derived RV/LV T2-ratio is an easily applicable tool bearing prognostic potential for CHF after STEMI.
METHODS: Six hundred four patients were enrolled after revascularized first-time STEMI; all patients underwent CMR within four days afterwards (interquartile range (IQR) 2-5). T2 relaxation times were measured in the RV and LV blood pool on short-axis T2-maps; T2-ratio was calculated as T2RV/T2LV. Telephonic follow-ups were performed at a median observation interval of 3.0 years. CHF was defined as cardiac decompensation symptoms requiring i.v. diuretics.
RESULTS: Median T2-ratio was 73% (IQR 65-80) and significantly lower in patients with newly diagnosed CHF (69% vs. 73%, p = 0.019). Dichotomized at 60% (10th percentile), patients with a reduced T2-ratio experienced CHF significantly more often (19% vs. 6%, p < 0.001) and sooner (55 vs. 485 days, p < 0.001) and were significantly older, had larger infarcts, higher peak troponin T, N-terminal pro-brain natriuretic peptide (NT-proBNP), lower LV-/RV-ejection fraction, and more commonly microvascular injuries (all p < 0.05). In logistic regression, T2-ratio < 60% emerged as an independent prognostic marker in multiparametric models including classic CHF risk factors. Addition of RV/LV T2-ratio to NT-proBNP resulted in a net reclassification improvement of 0.32 (95% CI 0.06-0.57, p = 0.016).
CONCLUSION: CMR-derived RV/LV T2-ratio is an easily applicable tool bearing prognostic potential for CHF after STEMI.